✦ LIBER ✦

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence

✍ Scribed by Adam Bisaga; Maria A. Sullivan; Wendy Y. Cheng; Kenneth M. Carpenter; John J. Mariani; Frances R. Levin; Wilfrid N. Raby; Edward V. Nunes

Book ID: 116412930
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 447 KB
Volume: 119
Category: Article
ISSN: 0376-8716
DOI: 10.1016/j.drugalcdep.2011.05.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled trial of memantine

A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence

✍ Bisaga, Adam; Sullivan, Maria A.; Glass, Andrew; Mishlen, Kaitlyn; Carpenter, Ke 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Low-dose amitriptyline as an adjunct to

Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: A placebo-controlled trial

✍ Kerrick, Jill M.; Fine, Perry G.; Lipman, Arthur G.; Love, Georgette 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 597 KB

Randomized Trial of Long-Acting Sustaine

Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence

✍ Krupitsky, Evgeny; Zvartau, Edwin; Blokhina, Elena; Verbitskaya, Elena; Wahlgren 📂 Article 📅 2012 🏛 American Medical Association 🌐 English ⚖ 218 KB

A placebo-controlled trial of midazolam

A placebo-controlled trial of midazolam as an adjunct to morphine patient-controlled analgesia after spinal surgery

✍ Day, Melissa A.; Rich, Martha Anne; Thorn, Beverly E.; Berbaum, Michael L.; Mang 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Masitinib as an adjunct therapy for mild

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

✍ François Piette, Joël Belmin, Hélène Vincent… 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 349 KB

A multicenter double-blind placebo-contr

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; M. Muenter; H. Klawans; H. Hurtig; M. Stern; I. Shoul 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

## Abstract Three hundred and seventy‐six subjects with advanced Parkinson's disease participated in a prospective, double‐blind placebo‐controlled study of the dopamine agonist pergolide mesylate as an adjunct to Sinemet®. At 6 months, patients randomized to pergolide had a statistically singnific